PT95827A - Processo para a preparacao de composicoes farmaceuticas para combater retrovirus, contendo como ingredientes activos acidos carboxilicos com enxofre - Google Patents

Processo para a preparacao de composicoes farmaceuticas para combater retrovirus, contendo como ingredientes activos acidos carboxilicos com enxofre

Info

Publication number
PT95827A
PT95827A PT95827A PT9582790A PT95827A PT 95827 A PT95827 A PT 95827A PT 95827 A PT95827 A PT 95827A PT 9582790 A PT9582790 A PT 9582790A PT 95827 A PT95827 A PT 95827A
Authority
PT
Portugal
Prior art keywords
preparation
pharmaceutical compositions
carboxyls
combating
retrovirus
Prior art date
Application number
PT95827A
Other languages
English (en)
Other versions
PT95827B (pt
Inventor
Joachim Kalden
Bernhard Fleckenstein
Andreas Baur
Thomas Harrer
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of PT95827A publication Critical patent/PT95827A/pt
Publication of PT95827B publication Critical patent/PT95827B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT95827A 1989-11-09 1990-11-08 Processo para a preparacao de composicoes farmaceuticas para combater retrovirus, contendo como ingredientes activos acidos carboxilicos com enxofre PT95827B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3937325 1989-11-09
DE4015728 1990-05-16

Publications (2)

Publication Number Publication Date
PT95827A true PT95827A (pt) 1991-09-13
PT95827B PT95827B (pt) 1997-11-28

Family

ID=25886910

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95827A PT95827B (pt) 1989-11-09 1990-11-08 Processo para a preparacao de composicoes farmaceuticas para combater retrovirus, contendo como ingredientes activos acidos carboxilicos com enxofre

Country Status (19)

Country Link
US (1) US5334612A (pt)
EP (1) EP0427246B1 (pt)
JP (1) JPH03188021A (pt)
AT (2) AT500684B8 (pt)
BE (2) BE1003834A5 (pt)
CA (1) CA2029599C (pt)
CH (1) CH684054A5 (pt)
DE (3) DE9017987U1 (pt)
DK (3) DK0427246T3 (pt)
ES (2) ES2029769A6 (pt)
FR (1) FR2653997B1 (pt)
GB (1) GB2239797B (pt)
GR (3) GR1001503B (pt)
IE (1) IE67874B1 (pt)
IT (1) IT1246328B (pt)
LU (1) LU87834A1 (pt)
NL (1) NL9002438A (pt)
PT (1) PT95827B (pt)
SE (1) SE508601C2 (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59209162D1 (de) * 1991-07-05 1998-03-05 Asta Medica Ag Verwendung von Schwefel enthaltenden Carbonsäuren zur Bekämpfung von pathophysiologisch bedingten Erregungsstörungen
DE4201196C2 (de) * 1992-01-18 1997-05-15 Rabien Margarethe Arzneimittel zur Behandlung der Polyneuropathie
DE4320117A1 (de) * 1992-01-18 1994-12-22 Margarethe Rabien Kombinatinspräparate
ES2111659T3 (es) * 1992-03-11 1998-03-16 Asta Medica Ag Comprimidos, granulados y nodulos con alto contenido en sustancias activas para formas de administracion solidas de alta concentracion.
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE9213914U1 (de) * 1992-10-15 1992-12-03 Asta Medica AG, 6000 Frankfurt Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure
EP0690709A1 (en) * 1993-03-26 1996-01-10 DINU, Constantin Romulus Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4317173C2 (de) * 1993-05-22 1995-06-14 Asta Medica Ag Verwendung von Dihydroliponsäure als Ophthalmologicum
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
DE4433764A1 (de) 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
CA2260128A1 (en) * 1996-07-05 1998-01-15 William G. Rice Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
WO1998023606A1 (fr) * 1996-11-27 1998-06-04 Fuji Kagaku Kogyo Kabushiki Kaisha Derives dithio cycliques, remedes contre des maladies renales diabetiques, agents hypoglycemiques, agents hypolipidemiques et agents lenitifs contre les troubles digestifs
US6090842A (en) 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
AU775388B2 (en) * 1998-11-25 2004-07-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Scavenger compounds
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
DE10045904B4 (de) * 1999-10-01 2007-07-12 Degussa Gmbh alpha-Liponsäure(-Derivate) enthaltende Retardform
WO2001024795A1 (de) * 1999-10-01 2001-04-12 Skw Trostberg Aktiengesellschaft α-LIPONSÄURE(-DERIVATE)ENTHALTENDE RETARDFORM
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
WO2001093824A1 (en) * 2000-06-06 2001-12-13 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US6649610B1 (en) 2001-05-23 2003-11-18 University Of Central Florida 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
US6683110B1 (en) 2001-05-23 2004-01-27 University Of Central Florida Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis
US6852876B1 (en) 2001-06-08 2005-02-08 University Of Central Florida Treatment of colon cancer
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
US6686496B1 (en) 2001-06-08 2004-02-03 University Of Central Florida Treatment of myeloma
WO2003072052A2 (en) * 2002-02-22 2003-09-04 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
US20040133938A1 (en) * 2002-11-19 2004-07-08 Yinghui Dan Use of lipoic acid in plant culture media
DE10318045A1 (de) * 2003-04-17 2004-11-04 Basf Ag Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung
JP4716666B2 (ja) * 2003-05-21 2011-07-06 有限会社オガ リサーチ α−リポ酸含有水性製剤
CN100422134C (zh) * 2004-03-12 2008-10-01 北京天衡药物研究院 新的2-（α-正戊酮基）苯甲酸盐及其制法和用途
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
WO2006134609A2 (en) * 2005-06-16 2006-12-21 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
BRPI0621285A2 (pt) * 2006-01-31 2011-12-06 Parsroos Co método para a preparação de um extrato vegetal e processo de produção de uma composição farmacêutica para estìmulo imunológico e/ou tratamento de infecções por hiv que compreende o referido extrato vegetal
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EA200901011A1 (ru) * 2009-06-08 2010-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Белагроген" Препарат на основе интерферона
CN107820422B (zh) * 2015-05-21 2022-02-08 摩纳哥奥夫塔尔米斯公司 包含硫辛酸和类粘液状聚合物的眼用组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA901960A (en) * 1972-06-06 Rossler Richard PROCESS FOR STABILIZING .alpha.-LIPOIC ACID IN PHARMACEUTICAL SOLUTIONS
US2840505A (en) * 1954-04-09 1958-06-24 Du Pont Process of treating animals for metal poisoning with thio-compounds
US2875227A (en) * 1955-05-11 1959-02-24 Merck & Co Inc Ephedrine salts of 7-carboethoxy-3-acetylthioheptanoic acid
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions
DE1617740B1 (de) * 1967-09-25 1971-11-04 Pfrimmer & Co J Verfahren zum Stabilisieren von Alfa-Liponsäure
DE1668887B2 (de) * 1968-03-15 1976-06-16 Ca-salz der 1,2 -dithia-cyclopentan - 3- valerian saeure gleich (thioctsaeure)
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
JPS5026516A (pt) * 1973-07-07 1975-03-19
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
EP0127012A3 (en) * 1983-05-30 1987-05-27 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPS60146829A (ja) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk テストステロン５α−リダクタ−ゼ阻害剤
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
EP0159519A3 (de) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
PT82199B (pt) * 1985-03-16 1990-11-07 Wellcome Found Processo para a preparacao de nucleosidos antivirais e de composicoes farmaceuticas que os contem
DE3512911A1 (de) * 1985-04-11 1986-10-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von 1,2-dithiolan-3-pentansaeure (thioctsaeure)
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
JP2543096B2 (ja) * 1987-09-24 1996-10-16 松下電器産業株式会社 燃焼装置
ATE70974T1 (de) * 1987-12-04 1992-01-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
DE3840076A1 (de) * 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
JPH01203336A (ja) * 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
DK0427247T3 (da) * 1989-11-09 1998-09-28 Asta Medica Ag Lægemiddel indeholdende R-alpha- lipoinsyre eller S-alphalipoinsyre som aktiv bestanddel
JPH10203336A (ja) * 1997-01-17 1998-08-04 Aisin Seiki Co Ltd アンチスキッド制御装置

Also Published As

Publication number Publication date
GB9024252D0 (en) 1990-12-19
IT9048456A1 (it) 1992-05-08
JPH03188021A (ja) 1991-08-16
SE9003564L (sv) 1991-06-07
DE9017987U1 (de) 1993-12-09
IT1246328B (it) 1994-11-17
DK173585B1 (da) 2001-04-02
ATE126053T1 (de) 1995-08-15
GB2239797A (en) 1991-07-17
ES2076279T3 (es) 1995-11-01
DK0427246T3 (da) 1995-11-27
EP0427246A2 (de) 1991-05-15
DE4035456A1 (de) 1991-05-16
IT9048456A0 (it) 1990-11-08
CA2029599C (en) 1998-08-11
CH684054A5 (de) 1994-07-15
BE1003834A5 (fr) 1992-06-23
DK200001239A (da) 2000-08-22
NL9002438A (nl) 1991-06-03
GR900100796A (en) 1992-04-17
DK267790D0 (da) 1990-11-08
BE1005018A3 (fr) 1993-03-23
AT500684B1 (de) 2006-10-15
ES2029769A6 (es) 1992-09-01
DK173752B1 (da) 2001-09-10
GR1001503B (el) 1994-02-28
GR3017695T3 (en) 1996-01-31
SE9003564D0 (sv) 1990-11-08
IE904035A1 (en) 1991-05-22
EP0427246A3 (en) 1992-06-03
DE59009497D1 (de) 1995-09-14
IE67874B1 (en) 1996-05-01
FR2653997A1 (fr) 1991-05-10
CA2029599A1 (en) 1991-05-10
LU87834A1 (de) 1991-05-07
GB2239797B (en) 1994-06-15
PT95827B (pt) 1997-11-28
US5334612A (en) 1994-08-02
FR2653997B1 (fr) 1995-01-20
EP0427246B1 (de) 1995-08-09
SE508601C2 (sv) 1998-10-19
GR1000918B (el) 1993-03-16
DK267790A (da) 1991-05-10
AT500684B8 (de) 2006-11-15
AT500684A1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
PT95827A (pt) Processo para a preparacao de composicoes farmaceuticas para combater retrovirus, contendo como ingredientes activos acidos carboxilicos com enxofre
KR890701559A (ko) 3-인돌피루브산 유도체 및 그의 제약 용도
KR880006193A (ko) 피페리딘 화합물 및 그의 제조 및 용도
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
KR890016966A (ko) 신규 항바이러스제
ES2112874T3 (es) Utilizacion de acidos carboxilicos con contenido en azufre para combatir trastornos de excitacion de origen patofisiologico.
KR950701922A (ko) 치환된 트리아졸의 설페이트 염, 이를 포함하는 약제학적 조성물 및 치료요법에서의 이의 용도(The sulphate salt of a substituted triazole, pharmaceutical compositions thereof and their use in therapy)
KR880009654A (ko) 아세트알데히드의 독성을 감소시키는 조성물 및 방법
KR890003378A (ko) 혐기성균에 대해 항균작용을 갖는 나프티리딘 화합물
KR870006035A (ko) 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법
KR910004192A (ko) 프로페니토인의 치료적 유효량을 함유하는 발작증 치료용 제약 조성물
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR920703067A (ko) 말초 신경질환 및 뇌질환 치료용 L-α-글리세로포르포릴-D-미오-이노시톨
US4391809A (en) Methods for treating psoriasis
PT97164A (pt) Processo para a estabilizacao de uma preparacao que contenham o composto 4-etil-2-hidroxi-imino-5-nitro-3-hexenamida e de composicoes farmaceuticas que o contenham
US3322627A (en) Method of treating herpes simplex infections with 5-methylamino-2'-deoxyuridine, and compositions therefor
KR870001144A (ko) Nn-디메틸에틸옥사이드가 함유된 약제조성물 및 그의 생산방법
KR870001153A (ko) 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
OA07773A (fr) "Dithiodiacétamides cycliques, procédé pour leur préparation et compositions pharmaceutiques en contenant".
CA1275932C (en) Solution containing luprostiol
DE974353T1 (de) Verwendung von Homocysteinderivaten zur Bereitung eines Medikaments zur verhinderung der Bakterienadhesion
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
US2598004A (en) Stabilized tetrathiodilactic and tetathiodiglycollic acid pharmaceutical
KR880012577A (ko) 티아디아졸 구아니딘 화합물 및 이의 제조방법

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910404

FG3A Patent granted, date of granting

Effective date: 19970812

PC3A Transfer or assignment

Free format text: ASTA MEDICA HEALTH PRODUCTS GMBH & CO. KG DE

Effective date: 20020909

PD3A Change of proprietorship

Free format text: VIATRIS GMBH & CO. KG DE

Effective date: 20020909

Free format text: ASTA MEDICA GMBH DE

Effective date: 20020909

TE3A Change of address (patent)

Free format text: ASTA MEDICA AKTIENGESELLSCHAFT DE

Effective date: 20020909

TE3A Change of address (patent)

Free format text: VIATRIS GMBH & CO. KG DE

Effective date: 20050506

PC4A Transfer of assignment

Owner name: EVONIK DEGUSSA GMBH, DE

Effective date: 20081027

PD4A Change of proprietorship

Owner name: MEDA PHARMA GMBH & CO. KG, DE

Effective date: 20081015

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20120813